Molecular structure of Methyl 8-chloro-8-oxooctanoate, CAS Number: 41624-92-4
Methyl 8-chloro-8-oxooctanoate (CAS 41624-92-4)
Alternate Names:
Methyl suberyl chloride
CAS Number:
41624-92-4
Purity:
≥95%
Molecular Weight:
206.67
Molecular Formula:
C9H15ClO3
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.
QUICK LINKS
Ordering Information
Description
Technical Information
Safety Information
SDS & Certificate of Analysis
Methyl 8-chloro-8-oxooctanoate (M8C8O) is a derivative of octanoic acid and is used as a building block for the synthesis of various compounds. For example, it has been used in the synthesis of pesticides, peptides, proteins, fluorescent dyes, and fluorescent proteins. Methyl 8-chloro-8-oxooctanoate acts as an alkylating agent, meaning it is capable of forming covalent bonds with other molecules. Studies have shown that it can act as an inhibitor of enzymes involved in the metabolism of fatty acids, carbohydrates, and proteins, as well as enzymes involved in the synthesis of proteins, DNA, RNA, and hormones, such as insulin and glucagon.
Methyl 8-chloro-8-oxooctanoate (CAS 41624-92-4) References
- 8-cyclopentadienyltricarbonyl 99mtc 8-oxooctanoic acid: a novel radiotracer for evaluation of medium chain fatty acid metabolism in the liver. | Lee, BC., et al. 2004. Bioconjug Chem. 15: 121-7. PMID: 14733591
- Synthesis and Biological Evaluation of JAHAs: Ferrocene-Based Histone Deacetylase Inhibitors. | Spencer, J., et al. 2011. ACS Med Chem Lett. 2: 358-362. PMID: 21572592
- In vivo PET imaging of histone deacetylases by 18F-suberoylanilide hydroxamic acid (18F-SAHA). | Hendricks, JA., et al. 2011. J Med Chem. 54: 5576-82. PMID: 21721525
- A cyclodextrin-capped histone deacetylase inhibitor. | Amin, J., et al. 2013. Bioorg Med Chem Lett. 23: 3346-8. PMID: 23591111
- Histone-deacetylase-targeted fluorescent ruthenium(II) polypyridyl complexes as potent anticancer agents. | Ye, RR., et al. 2013. Chemistry. 19: 10160-9. PMID: 23828334
- A phosphorescent rhenium(I) histone deacetylase inhibitor: mitochondrial targeting and paraptosis induction. | Ye, RR., et al. 2015. Chem Commun (Camb). 51: 8353-6. PMID: 25882790
- Discovery, bioactivity and docking simulation of Vorinostat analogues containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors and antitumor agents. | Cai, J., et al. 2015. Bioorg Med Chem. 23: 3457-71. PMID: 25953722
- A novel method for determining peroxisomal fatty acid β-oxidation. | Morita, M., et al. 2016. J Inherit Metab Dis. 39: 725-731. PMID: 27324171
- Synthesis and Evaluation of 2-[18F]Fluoroethyltriazolesuberohydroxamine Acid for Histone Deacetylase in a Tumor Model as a Positron Emission Tomography Radiotracer. | Kim, IS., et al. 2018. Cancer Biother Radiopharm. 33: 52-59. PMID: 29498544
- Anticancer RuII and RhIII Piano-Stool Complexes that are Histone Deacetylase Inhibitors. | Cross, JM., et al. 2016. Chempluschem. 81: 1276-1280. PMID: 31964062
- Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer Cells. | Romanelli, A., et al. 2020. ACS Med Chem Lett. 11: 977-983. PMID: 32435414
- Procainamide-SAHA Fused Inhibitors of hHDAC6 Tackle Multidrug-Resistant Malaria Parasites. | Nardella, F., et al. 2021. J Med Chem. 64: 10403-10417. PMID: 34185525
- Zoledronic acid inhibits osteoclastogenesis and bone resorptive function by suppressing RANKL‑mediated NF‑κB and JNK and their downstream signalling pathways. | Huang, XL., et al. 2022. Mol Med Rep. 25: PMID: 34935053
- Effects of Regioisomerism on the Antiproliferative Activity of Hydroxystearic Acids on Human Cancer Cell Lines. | Calonghi, N., et al. 2022. Molecules. 27: PMID: 35458594
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Methyl 8-chloro-8-oxooctanoate, 1 g | sc-235807 | 1 g | $128.00 |